All questions
Question 1
Twin infants born at 28 weeks gestation are now 6 weeks old. Twin A weighs 2.1 kg and Twin B weighs 1.9 kg. Both require identical testing: daily glucose monitoring (0.15 mL per test) and weekly laboratory studies (3.2 mL). After 5 days of daily glucose monitoring, Twin A develops anemia with hemoglobin dropping from 12.1 g/dL to 9.8 g/dL. How should blood collection be modified for the remainder of the week?
- Continue identical collection schedules since both twins have similar gestational age and current weights are comparable
- Reduce Twin A's glucose monitoring to every 12 hours and postpone weekly labs for 3 days to allow hematologic recovery
- Switch Twin A to point-of-care glucose testing requiring smaller volumes while maintaining current schedule for Twin B
- Calculate individual volume limits for each twin and adjust Twin A's collection frequency based on cumulative volume and current anemia (correct answer)
Explanation: Each infant requires individual volume calculation despite similar characteristics. Twin A (2.1 kg): blood volume ≈ 189 mL, weekly limit ≈ 3.8 mL. Twin B (1.9 kg): blood volume ≈ 171 mL, weekly limit ≈ 3.4 mL. After 5 days of glucose monitoring, each has had 0.75 mL collected. Twin A's developing anemia (significant drop from 12.1 to 9.8 g/dL) indicates poor tolerance to blood loss, requiring immediate volume reduction. Individual assessment considering weight differences, cumulative volumes, and current hematologic status is essential. Weekly labs (3.2 mL) would exceed safe limits for both infants, but Twin A's anemia makes this critical. Choice A ignores individual patient status. Choice B delays without proper volume calculation. Choice C doesn't address the fundamental volume limit problem and POC testing still requires blood samples.
Question 2
A 45-year-old patient with severe iron deficiency anemia (hemoglobin 6.8 g/dL, hematocrit 20%) weighing 68 kg requires blood collection for pre-transfusion testing. The blood bank requires: type and crossmatch (7.5 mL), antibody screen (3.0 mL), and direct antiglobulin test (2.5 mL). The patient had 5.2 mL collected yesterday for other pre-operative studies. What is the most critical consideration for this collection?
- The 13.0 mL total collection volume exceeds safe limits for anemic patients and requires volume reduction strategies
- The timing between collections is inadequate for patients with severe anemia requiring 48-hour intervals minimum
- Blood bank testing volumes cannot be reduced without compromising transfusion safety, requiring risk-benefit analysis (correct answer)
- The patient's severe anemia contraindicates any further blood collection until after transfusion therapy is completed
Explanation: Pre-transfusion testing requires specific volumes mandated by blood banking regulations and cannot be reduced without compromising patient safety. With severe anemia (Hgb 6.8 g/dL), the patient has critically reduced oxygen-carrying capacity, making blood loss potentially dangerous. However, transfusion cannot proceed safely without proper compatibility testing. The 13.0 mL required represents necessary medical intervention despite the patient's compromised state. This requires careful risk-benefit analysis, possible coordination with anesthesia for collection during surgery, or consideration of collection timing relative to transfusion. Choice A suggests volume reduction which isn't possible for blood bank specimens. Choice B incorrectly states timing requirements. Choice D would prevent life-saving transfusion therapy - the collection must proceed with appropriate monitoring and support.
Question 3
A premature infant born at 32 weeks gestation, now 2 weeks old and weighing 1.8 kg, requires blood glucose monitoring every 8 hours and weekly laboratory studies. The weekly labs require 2.2 mL total volume. Each glucose check requires 0.1 mL. Over a 7-day period, what is the maximum safe total blood volume that should be collected?
- 4.3 mL calculated as 2.2 mL for weekly labs plus 2.1 mL for glucose monitoring (21 checks × 0.1 mL)
- 1.8 mL representing 1% of body weight as the conservative limit for extremely premature infants
- 10.8 mL based on standard pediatric calculation of 6 mL per kg per week for this weight category
- 2.7 mL allowing for essential monitoring while maintaining safety margins for this high-risk population (correct answer)
Explanation: Premature infants require the most conservative blood volume calculations due to immature physiologic systems and limited blood volume reserves. Total blood volume for premature infants is approximately 85-100 mL/kg, so 1.8 kg × 90 mL/kg = 162 mL total blood volume. For extremely premature infants, the safe collection limit is typically 1-2% of total blood volume per week, which equals 1.6-3.2 mL maximum. The calculated needs (2.2 + 2.1 = 4.3 mL) exceed safe limits. Priority must be given to essential glucose monitoring (hypoglycemia risk in premature infants) while potentially reducing frequency of other labs or using micro-collection techniques. 2.7 mL represents a compromise allowing critical monitoring within safety parameters. Choice A ignores safety limits. Choice B is overly restrictive and may compromise essential care. Choice C applies standard pediatric calculations inappropriate for premature infants.
Question 4
An 85-year-old patient weighing 58 kg with mild anemia (hemoglobin 9.2 g/dL) and taking anticoagulant medication requires blood collection for therapeutic drug monitoring. The standard collection volume for this test is 5 mL, but the patient had 8 mL drawn yesterday for other laboratory work. What volume adjustment should be considered for today's collection?
- Collect the full 5 mL as therapeutic drug monitoring requires precise volume ratios for accurate results
- Reduce collection to 3 mL and coordinate with laboratory to ensure adequate sample for testing requirements (correct answer)
- Postpone collection for 48 hours to allow physiologic recovery from previous blood loss in this high-risk patient
- Collect 4 mL using pediatric tubes to minimize volume while maintaining anticoagulant ratio requirements for testing
Explanation: Elderly patients with anemia and anticoagulation represent high-risk populations requiring volume reduction strategies. With hemoglobin of 9.2 g/dL (below normal 12-15 g/dL for women, 14-17 g/dL for men), the patient has reduced oxygen-carrying capacity. Combined with recent 8 mL collection and anticoagulant therapy increasing bleeding risk, volume reduction is appropriate. Most therapeutic drug monitoring can be performed on smaller volumes (2-3 mL) with laboratory coordination. Choice A ignores patient risk factors. Choice C may delay critical therapeutic monitoring unnecessarily. Choice D incorrectly suggests pediatric tubes maintain proper anticoagulant ratios - tube selection should be based on final volume needed, not patient population, and 4 mL may still be too much given the risk factors.
Question 5
A 78-year-old patient with chronic kidney disease (creatinine 2.8 mg/dL) and heart failure weighing 72 kg requires weekly monitoring. Standard weekly collections include: electrolyte panel (1.5 mL), renal function tests (2.0 mL), cardiac biomarkers (1.8 mL), and CBC (1.2 mL). The patient also needs monthly coagulation studies (1.5 mL) this week. What is the most appropriate volume management strategy?
- Collect all tests as ordered (8.0 mL total) since this represents less than 1% of total blood volume for this patient weight
- Coordinate with laboratory to use smaller aliquots and collect 5.5 mL total, combining compatible tests in single tubes (correct answer)
- Postpone monthly coagulation studies to next week and collect 6.5 mL for essential weekly monitoring only
- Use point-of-care testing for electrolytes and glucose to reduce venipuncture volume to 4.5 mL total
Explanation: Elderly patients with multiple comorbidities (chronic kidney disease and heart failure) require careful volume management even when calculated volumes seem acceptable. While 8.0 mL represents less than 0.2% of total blood volume, patients with kidney disease may have altered fluid balance and reduced ability to compensate for blood loss. Heart failure patients may have compromised cardiovascular reserve. Laboratory coordination to optimize tube usage and reduce total volume while maintaining test integrity is the best approach. Many chemistry tests can be run from the same tube, and micro-collection techniques can reduce required volumes. Choice A doesn't consider patient comorbidities. Choice C unnecessarily delays important monitoring. Choice D may not provide the precision needed for monitoring these serious conditions and doesn't address the volume concern comprehensively.
Question 6
A 4-year-old patient weighing 16 kg requires blood collection for suspected metabolic disorder. The testing laboratory specifies minimum volumes: amino acid analysis (3.5 mL), organic acid screen (2.8 mL), and fatty acid profile (2.2 mL). The laboratory cannot perform these tests on smaller volumes due to analytical sensitivity requirements. The child had 4.1 mL collected 5 days ago. How should the phlebotomist proceed with this collection?
- Collect all required volumes (8.5 mL total) since metabolic testing is diagnostic priority and previous collection was over 72 hours ago
- Split collections over two days: collect 4.5 mL today and 4.0 mL tomorrow to stay within daily collection limits
- Collect 6.2 mL maximum based on weekly volume calculations and prioritize most critical tests with physician consultation (correct answer)
- Use capillary collection methods to obtain required volumes while minimizing impact on venous blood volume reserves
Explanation: For a 16 kg child, total blood volume = 16 × 75 = 1,200 mL. Weekly safe collection limit = 5% = 60 mL maximum. Previous collection (4.1 mL) plus required collection (8.5 mL) = 12.6 mL, which is within weekly limits. However, single-collection safety limits for pediatric patients typically restrict large volume draws. The requested 8.5 mL represents a substantial single collection requiring risk-benefit analysis. Collecting 6.2 mL allows for the most critical tests while maintaining safety margins, with physician consultation to prioritize which tests are most essential for immediate diagnosis. Choice A doesn't consider single-draw volume limits. Choice B may compromise test integrity if samples degrade between collections and doesn't address volume limit concerns. Choice D is impractical - capillary collection cannot provide the large volumes needed for these specialized metabolic tests.
Question 7
A neonatal intensive care unit protocol requires blood volume tracking for all patients under 2.5 kg. A 1.6 kg neonate has had the following collections over 6 days: Day 1 (0.8 mL), Day 2 (1.2 mL), Day 4 (0.6 mL), Day 5 (0.9 mL). Today (Day 6), orders include arterial blood gas (0.3 mL), glucose (0.1 mL), and electrolytes (0.4 mL). The neonate's hematocrit has decreased from 45% to 38% over this period. What action should be taken?
- Review cumulative weekly volume against established limits and assess if hematocrit decline is related to blood loss (correct answer)
- Collect only arterial blood gas and glucose (0.4 mL total) and defer electrolytes until tomorrow due to cumulative volume concerns
- Proceed with all ordered tests (0.8 mL) since daily volume is within acceptable limits for this patient weight
- Postpone all collections for 24 hours to allow hematologic recovery given the significant hematocrit decrease
Explanation: When you encounter questions about neonatal blood collection, always think comprehensively about cumulative volume limits, patient safety, and clinical correlation. Neonates have limited blood volume (approximately 80-90 mL/kg), making volume tracking critical to prevent iatrogenic anemia.
The correct approach is A because it addresses all essential elements: reviewing cumulative weekly volume against established limits and correlating the hematocrit decline with blood loss. Over 6 days, this 1.6 kg neonate has had 3.5 mL collected, with 0.8 mL requested today (4.3 mL total). The 7-point hematocrit drop (45% to 38%) requires clinical correlation to determine if it's related to blood draws or underlying pathology. This comprehensive assessment ensures patient safety while maintaining appropriate monitoring.
B is incorrect because arbitrarily reducing collections without proper volume assessment could compromise patient care, and the decision lacks clinical rationale for which tests to defer.
C is wrong because it ignores the cumulative volume concern and the significant hematocrit decline. While 0.8 mL might seem acceptable for daily limits, the total weekly volume and clinical changes must be considered.
D is inappropriate because it postpones all medically necessary testing without proper assessment. The hematocrit decline alone doesn't automatically warrant stopping all collections—clinical correlation is needed first.
Study tip: For neonatal phlebotomy questions, always consider the "big picture": cumulative volumes, patient weight, clinical changes, and correlation between laboratory values and blood loss. Never make collection decisions based on single parameters alone.